Ronald E. Pruitt

Biochemistry, Genetics and Molecular Biology · Life Sciences

15h-index2.9kcitations57works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Inflammatory Bowel Disease(18), Esophageal Cancer Research and Treatment(13), Esophageal and GI Pathology(9), Microscopic Colitis(9), Helicobacter pylori-related gastroenterology studies(8)

Publications57 total

Perspective on this Article from Five-Year Efficacy and Safety Analysis of the Adenoma Prevention with Celecoxib Trial
2023Open Access
Supplementary Information from Five-Year Efficacy and Safety Analysis of the Adenoma Prevention with Celecoxib Trial
2023Open Access
Data from Five-Year Efficacy and Safety Analysis of the Adenoma Prevention with Celecoxib Trial
2023Open Access
Perspective on this Article from Five-Year Efficacy and Safety Analysis of the Adenoma Prevention with Celecoxib Trial
2023Open Access
Data from Five-Year Efficacy and Safety Analysis of the Adenoma Prevention with Celecoxib Trial
2023Open Access
Supplementary Information from Five-Year Efficacy and Safety Analysis of the Adenoma Prevention with Celecoxib Trial
2023Open Access
Focus on...
Gastrointestinal Endoscopy·2018Open Access
A phase III study evaluating the efficacy and safety of remimazolam (CNS 7056) compared with placebo and midazolam in patients undergoing colonoscopy
Gastrointestinal Endoscopy·2018· 296 citedOpen Access
A phase III study evaluating the efficacy and safety of remimazolam (CNS 7056) compared with placebo and midazolam in patients undergoing colonoscopy
2018
Once-daily mesalamine granules for maintaining remission of ulcerative colitis: pooled analysis of efficacy, safety, and prognostic factors
Postgraduate Medicine·2016· 12 cited
AVX-470, an Orally Delivered Anti-Tumour Necrosis Factor Antibody for Treatment of Active Ulcerative Colitis: Results of a First-in-Human Trial
Journal of Crohn s and Colitis·2016· 71 cited
Daclatasvir plus simeprevir with or without ribavirin for the treatment of chronic hepatitis C virus genotype 1 infection
Journal of Hepatology·2015· 43 citedOpen Access
Once-daily Mesalamine Formulation for Maintenance of Remission in Ulcerative Colitis
Journal of Clinical Gastroenterology·2015· 25 citedOpen Access
Tu1560 The Effect of Pre-Treatment Stricture on Outcomes After Radiofrequency Ablation (RFA) for Barrett's Esophagus: Results From the U.S. RFA Registry
Gastrointestinal Endoscopy·2015
239 Barrett's Esophagus Advanced Neoplasia Calculator (BANC): A Personalized, Web-Based Predictive Model of High Grade Dysplasia and Adenocarcinoma Following Successful Eradication of Barrett's Esophagus With Radiofrequency Ablation
Gastroenterology·2015
Sa1078 Choice of Initial Radiofrequency Ablation Treatment Device in Barrett's Esophagus Is Associated With Different Rates of Recurrence and Complications
Gastroenterology·2015
240 Downward Trend in H. pylori Infection and Corresponding Changes of Often-Seen Upper Gastrointestinal Diseases in Southeastern China in Last Decade
2015
Safety of ABT-450/r/Ombitasvir plus Dasabuvir With or Without Ribavirin in HCV Genotype 1-infected Patients: Results From PEARL II, PEARL III, and PEARL IV
Bursa Uludag University - AVESIS·2014
Long-term Safety and Tolerability of Twice-daily Balsalazide Disodium Tablets in Patients with Ulcerative Colitis
The American Journal of Gastroenterology·2013· 2 cited
Su1022 What Is the Histology of Subsquamous Intestinal Metaplasia (SSIM) in Patients With Prior Radiofrequency Ablation (RFA) for Treatment of Barrett's Esophagus (BE)? Results From the U.S. RFA Registry
Gastroenterology·2013
page 1 of 3Next →

Frequent Co-authors

Charles J. Lightdale(9), Monica M. Bertagnolli(8), Craig Eagle(8), Ann G. Zauber(8), Mark Redston(8), Rebecca B. Rosenstein(8), Donya Bagheri(8), John Burn(8), Daniel C. Chung(8), T. Raymond Foley(8), Neville E. Hoffman(8), Finlay Macrae(8), John R. Saltzman(8), Bruce Salzberg(8), Thomas Sylwestrowicz(8), Ernest T. Hawk(8), Nicholas J. Shaheen(8), Aurora Breazna(7), KyungMann Kim(7), Asad Umar(7)